CD274 and non-small cell lung carcinoma: The utility of antibody-based PD-L1 PET in irradiated NSCLC tumours has also been investigated by Ehlerding et al. [15], who also demonstrated a significant increase in tumour uptake of 89Zr-DFO-atezolizumab after radiotherapy.